Zenapax to Treat Multiple Sclerosis

Clinical Trial ID NCT00001934

PubWeight™ 3.39‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00001934

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995 5.82
2 Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992 4.39
3 Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis. Arch Neurol 2009 2.06
4 Daclizumab therapy for multiple sclerosis. Neurotherapeutics 2013 1.33
5 Molecular mimicry and multiple sclerosis: degenerate T-cell recognition and the induction of autoimmunity. Ann Neurol 1999 1.11
Next 100